CPA
QDEL icon

Capital Performance Advisors’s QuidelOrtho QDEL Stock Holding History

Capital Performance Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-541
Closed -$24.7K – 2064
2024
Q3 		$24.7K Buy
+541
New +$21.9K 0.01% 540

Other funds holding QDEL

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Performance Advisors's QDEL Position: Q4 2024 in Review

Capital Performance Advisors sold out of QuidelOrtho (QDEL) in Q4 2024, closing a stake of 541 shares — an estimated $24.7K sold.

Capital Performance Advisors first reported a position in QDEL in Q3 2024 and held it in 1 quarter. The position peaked at $24.7K in Q3 2024. 274 funds tracked by Wall St. Rank hold QDEL as of Q4 2024.

  • Capital Performance Advisors reported no remaining QuidelOrtho position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 541 QuidelOrtho shares in Q4 2024, an estimated $24.7K.
  • Capital Performance Advisors first reported a position in QuidelOrtho in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's QuidelOrtho position peaked at $24.7K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.